Treatment of cervical cancer in Italy: Strategies and their impact on the women

Vaccine

Volumn 27, Issue SUPPL. 1, 2009, Pages

  De Vincenzo, Rosa ^a   Amadio, Giulia ^a   Ricci, Caterina ^a   Licameli, Angelo ^a   Ferrandina, Gabriella ^b   Capelli, Giovanni ^c   Scambia, Giovanni ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF CASSINO AND SOUTHERN LAZIO   (Italy)

Author keywords

Cervical cancer; Quality of life (QoL); Treatment

Indexed keywords

CISPLATIN; FLUOROURACIL; IFOSFAMIDE; NAVELBINE; PACLITAXEL;

ADJUVANT CHEMOTHERAPY; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EXPERIMENTAL THERAPY; FERTILITY; GYNECOLOGIC SURGERY; HEALTH CARE POLICY; HUMAN; ITALY; LAPAROSCOPIC SURGERY; LYMPH NODE; MONOTHERAPY; MORTALITY; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUALITY OF LIFE; RADICAL HYSTERECTOMY; SOCIAL PSYCHOLOGY; SURVIVAL RATE; SURVIVAL TIME; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CONIZATION; VAGINAL HYSTERECTOMY; VAGINAL TRACHELECTOMY;

CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INCIDENCE; ITALY; LAPAROSCOPY; NEOADJUVANT THERAPY; QUALITY OF LIFE; UTERINE CERVICAL NEOPLASMS;

EID: 65749115808     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.11.110     Document Type: Article

References (56)

1. Boyle P., Leon M.E., Maisonneuve P., and Autier P. Cancer control in women. Update 2003. Int J Gynecol Obstet 83 Suppl 1 (2003) 179-202
2. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
3. Franceschi S., Herrero R., Clifford G.M., Snijders P.J.F., Arslan A., Anh P.T.H., et al. Variations in the age-specific curves of human papillomavirus prevalence in women worldwide. International Agency for Research on Cancer, Lyon, France. Int J Cancer 119 11 (2006) 2677-2684
4. IARC Working Group on evaluation of cervical cancer screening programs. Screening for squamous cervical cancer: the duration of low risk after negative results of cervical cytology and its implication for screening polices. Br Med J 293 (1986) 659-664
5. Smith H.O., Tiffany M.F., Qualls C.R., and Key C.R. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States-a 24-years population based study. Gynecol Oncol 78 (2000) 79-105
6. Visioli C.B., Zappa M., Ciatto S., Iossa A., and Crocetti E. Increasing trends of cervical adenocarcinoma incidence in Central Italy despite Estensive Screening Programme 1985-2000. Cancer Detect Prev 28 (2004) 461-464
7. Fagotti A., Fanfani F., Longo R., Legge F., Mari A., Gagliardi M.L., et al. Which role for pre-treatment laparoscopic staging?. Gynecol Oncol 107 (2007) S101-S105
8. Marnitz S., Kohler C., Roth C., Fuller J., Hinkelbein W., and Schneider A. Is there a benefit of pre-treatment laparoscopic transperitoneal surgical staging in patients with advanced cervical cancer?. Gynecol Oncol 99 (2005) 536-544
9. Kohler C., Klemm P., Schau A., Possover M., Krause N., Tozzi R., et al. Introduction of transperitoneal lymphadenectomy in a gynaecologic oncology center: analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies. Gynecol Oncol 95 (2004) 52-61
10. Long H.J., Laack N.N., and Gostout B.S. Prevention, diagnosis, and treatment of cervical cancer. Mayo Clin Proc 82 12 (2007) 1566-1574
11. Hertel H., Kohler C., Michels W., Possover M., Tozzi R., and Schneider A. Laparoscopic-assisted radical vaginal hysterectomy (LARVH): prospective evaluation of 200 patients with cervical cancer. Gynecol Oncol 90 (2003) 505-511
12. Dargent D., Martin X., Sacchetoni A., and Mathevet P. Laparoscopic Vaginal radical trachelectomy. A treatment to preserve fertility of cervical carcinoma patients. Cancer 88 (2000) 1877-1882
13. Burnett A.F. Radical trachelectomy with laparoscopic lymphadenectomy: review of oncologic and obstetrical outcomes. Curr Opin Obstet Gynecol 18 1 (2006) 8-13
14. Plante M., Renaud M.C., Hoskins I.A., and Roy M. Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature. Gynecol Oncol 98 (2005) 3-10
15. Shepherd J.H., Spencer C., Herod J., and Ind T. Radical vaginal trachelectomy as a fertility-sparing procedure in women with early-stage cervical cancer-cumulative pregnancy rate in a series of 123 women. BJOG 113 (2006) 719-724
16. Marchiole P., Benchaib M., Buenerd A., Lazlo E., Dargent D., and Mathevet P. Oncological safety of laparoscopic-assisted vaginal radical trachelectomy (LARVT or Dargent's operation): a comparative study with laparoscopic-assisted vaginal radical hysterectomy (LARVH). Gynecol Oncol 106 (2007) 132-141
17. Maneo A., Landoni F., Caspani G., Fiana L., Signorelli M., Urso M., et al. Chemotherapy and conization for preserving fertility in stage IB1 cervical cancer. 2004 Proceeding International Gynecologic Cancer Society. Int J Gynecol Cancer 14 Suppl 1 (2004) 694
18. Landoni F., Parma G., Peiretti M., Zanagnolo V., Sideri M., Colombo N., et al. Chemo-conization in early cervical cancer. Gynecol Oncol 107 Suppl 1 (2007) S125-S126
19. Plante M., Lau S., Brydon L., Swenerton K., LeBlanc R., and Roy M. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy in bulky stage IB1 cervical cancer: case report. Gynecol Oncol 101 2 (2006) 367-370
20. Perez C.A., Camel H.M., Kuske R.R., Kao M.S., Galakatos A., Hederman M.A., et al. Radiation therapy alone in the treatment of carcinoma of the uterine cervix: a 20-year experience. Gynecol Oncol 23 (1986) 40-71
21. Beller U., Benedet J.L., Creasman W.T., Ngan H.Y., Quinn M.A., Maisonneuve P., et al. Carcinoma of the cervix uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 95 Suppl 1 (2006) S29-42
22. Keys H.M., Bundy B., Stehamn F.B., Muderspach L.I., Chafe W.E., Suggs C.L., et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med 15 (1999) 1154-1161
23. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenbach C., Stevens R.E., et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high risk cervical cancer. N Engl J Med 15 (1999) 1137-1143
24. Whitney C.W., Sause W., Bundt B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-VA carcinoma of the cervix with negative para-aortic lymph nodes. A Gynecologic Oncology Group and Southwest Oncology Group Study. J Clin Oncol 17 (1999) 1339-1348
25. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 15 (1999) 1144-1153
26. Peters W.A., Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol 18 (2000) 1606-1614
27. Benedetti-Panici P., Greggi S., Colombo A., Amoroso M., Smaniotto D., Giannarelli D., et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study. J Clin Oncol 20 (2002) 179-188
28. Rose P.G., Piver M.S., Malfetano J.H., Baker T.R., Hempling R.E., and Recio F.O. A phase II study of weekly cisplatin followed by cisplatin and ifosfamide in advanced or recurrent cervical carcinoma. Cancer 71 (1993) 2245-2249
29. Leone P., Vallejo C., Perez J., Cuevas M.A., Machiavelli M., Lacava J., et al. Ifosfamide and cisplatin as neoadjuvant chemotherapy for advanced cervical carcinoma. Am J Clin Oncol 19 (1996) 132-135
30. Mc Guire W.P., Blessing J.A., Moore D., Lentz S.S., and Photopulos G.L. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study. J Clin Oncol 14 (1996) 792-795
31. Zanetta G., Fei F., and Mangioni C. Chemotherapy with paclitaxel, ifosfamide and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza. Semin Oncol 27 Suppl 1 (2000) 23-27
32. Buda A., Fossati R., Colombo N., Fei F., Floriani I., Gueli Alletti D., et al. Randomized trial of neoadjuvant chemotherapy comparing Paclitaxel, ifosfamide, and cisplatin with ifosfamide and cisplatin followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the SNAP01 (studio neo-adjuvante portio) Italian collaborative study. J Clin Oncol 23 (2005) 4137-4145
33. Di Vagno G., Cormio G., Pignata S., Scambia G., Di Stefano M.G., Tambaro R., et al. Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study. Int J Gynecol Cancer 13 (2003) 308-312
34. Loizzi V., Cormio G., Vicino M., and Selvaggi L. Neoadjuvant chemotherapy: an alternative option of treatment for locally advanced cervical cancer. Gynecol Obstet Invest 65 (2008) 96-103
35. Benedetti Panici P., Scambia G., Greggi S., Di Roberto P., Baiocchi G., and Mancuso S. Neoadjuvant chemotherapy and radical surgery in locally advanced cervical carcinoma: a pilot study. Obstet Gynecol 71 (1998) 344-348
36. Jemal A., Murray T., Ward E., Samuels A., Tiwari R.C., Ghafoor A., et al. Cancer statistics. CA Cancer J Clin 55 (2005) 10-30
37. Resbeut M., Cowen D., Viens P., Noirclerc M., Perez T., Gouvernet J., et al. Concomitant chemoradiation prior to surgery in the treatment of advanced cervical carcinoma. Gynecol Oncol 54 (1994) 68-75
38. Jurado M., Martinez-Monge R., Garcia-Foncillas J., Azinovic I., Aristu J., Lopez-Garcia G., et al. Pilot study of concurrent cisplatin, 5-fluorouracil, and external beam radiotherapy prior to radiotherapy in locally advanced cervical cancer. Gynecol Oncol 74 1 (1999) 30-37
39. Ferrandina G., Legge F., Fagotti A., Fanfani F., Distefano M., Moranti A., et al. Preoperative concomitant chemoradiotherapy in locally advanced cervical cancer: safety, outcome and prognostic measures. Gynecol Oncol 107 (2007) S127-S132
40. Mancuso S., Smaniotto D., Benedetti Panici P., Favale B., Greggi S., Manfredi R., et al. Phase I-II trial of preoperative chemoradiation in locally advanced cervical carcinoma. Gynecol Oncol 78 (2000) 324-328
41. Distefano M., Fagotti A., Ferrandina G., Fanfani F., Smaniotto D., D'agostino G., et al. Preoperative chemoradiotherapy in locally advanced cervical cancer: long-term outcome and complications. Gynecol Oncol 99 Suppl 1 (2005) S166-S170
42. Cellini N., Smaniotto D., Scambia G., Luzi S., Balducci M., Ferrandina G., et al. Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. Am J Clin Oncol 31 3 (2008) 280-284
43. Piver M.S., Rutledge F., and Smith J.P. Five classes of extended hysterectomy for women with cervical cancer. Obstet Gynecol 44 (1974) 265-272
44. Trimbos J.B., Franchi M., Zanaboni F., Velden J., and Vergote I. State of the art of radical hysterectomy: current practice in European oncology centres. Eur J Oncol 40 (2004) 375-378
45. Goff B., Muntz H.G., Paley P.J., Tamimi H.K., Koh W.J., and Greer B.E. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol Oncol 74 (1999) 436-442
46. Cosin J.A., Fowler J.M., Chen M.D., Paley P.J., Carson L.F., and Twiggs L.B. Pretreatment surgical staging of patients with cervical carcinoma: the case for lymph node debulking. Cancer 82 (1998) 2241-2248
47. Benedetti Panici P., Cutillo G., and Angioli R. Modulation of surgery in early invasive cervical cancer. Crit Rev Oncol/Hematol 48 (2003) 263-270
48. Morice P., Castaigne D., Pautier P., et al. Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 73 (1999) 106-110
49. Benedetti Panici P., Angioli R., Palaia I., Muzii L., Zullo M.A., Manci N., et al. Tailoring the parametrectomy in stages IA2-IB1 cervical carcinoma: is it feasible and safe?. Gynecol Oncol 96 (2005) 792-798
50. Ferrandina G., Distefano M., Ludovisi M., Fagotti A., Fanfani F., and Scambia G. Assessment of pathological status of lower pelvic nodes to tailor surgery in not squamous early cervical carcinoma. Gynecol Oncol 99 1 (2005) 246-247
51. Scambia G., Ferrandina G., Distefano M., Fagotti A., Manfredi R., Zannoni G.F., et al. Is there a place for a less extensive radical surgery in locally advanced cervical cancer patients?. Gynecol Oncol 83 (2001) 319-324
52. Ferrandina G., Distefano M., Ludovisi M., Moranti A., Smaniotto D., D'Agostino G., et al. Lymph node involvement in locally advanced cervical cancer patients administered preoperative chemoradiation versus chemotherapy. Ann Surg Oncol 14 3 (2007) 1129-1135
53. Capelli G., De Vincenzo R., Addamo A., Bartolozzi F., Braggio N., and Scambia G. Which dimensions of health-related quality of life are altered in patients attending the different gynaecologic oncology health care settings?. Cancer 95 12 (2002) 2500-2507
54. Ware Jr. J.E., and Sherbourne C.D. The MOS 36-item short form health survey (SF-36). Conceptual framework and item selection. Med Care 30 (1992) 473-483
55. Distefano M., Riccardi S., Costantini B., Petrillo M., Ricci C., Scambia G., et al. Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy. Gynecol Oncol 111 1 (2008) 144-150 [Aug 7. Epub ahead of print]
56. Zigmond A.S., and Snaith R.P. The hospital anxiety and depression scale. Acta Psychiatr Scand 67 6 (1983) 361-370